Broadly Neutralizing Antibodies Delayed Rebound in HIV Patients Who Stopped ART

By News Health
3 months Ago

(MedPage Today) — SAN FRANCISCO — Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral therapy (ART) avoided rebound for 5 months, a randomized trial showed.
At 20 weeks from analytical…

Source link : https://www.medpagetoday.com/meetingcoverage/croi/114589

Author :

Publish date : 2025-03-11 15:02:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Mum of boy with PPFIBP1 gene says finding others gave her 'strength'

Novel Anticoagulant Flops for Staving Off Graft Thrombosis in Dialysis Patients

AI-Directed Breast MRI Could Lead to Faster Scan Times Without Affecting Accuracy

Home Testing Doubles Cervical Cancer Screening in Safety-Net Population

Infectious Disease Docs Slam New COVID Vaccine Recommendations

Some Psych Meds Tied to Higher Future Risk of ALS